Skip to main content
SpringerLink
Log in

Therapie der Mastodynie/Mastopathie

  • Conference paper
Gießener Gynäkologische Fortbildung 1989

  • 56 Accesses

Zusammenfassung

Im Rahmen der Abhandlung über die Therapie gutartiger Brusterkrankungen ist es zunächst notwendig, die zu behandelnden Erkrankungen der Mammae zu definieren. Leider berichten verschiedene Untersucher ihre Ergebnisse unter verschiedenen Begriffsanwendungen (Herrmann u. Walther 1983). Für die nachfolgenden therapeutischen Betrachtungen gilt für die Mastodynie, daß es sich dabei um schmerzhafte bzw. berührungsempfindliche Brüste handelt, wobei die Beschwerden zyklisch oder kontinuierlich vorliegen können.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Blackmore WP (1977) Danazol in the treatment of benign breast disease. J Int Med Res [Suppl 3] 5:101–108

    PubMed  Google Scholar 

  • Blichert-Toft M, Watt-Boolsen S (1984) Clinical approach to women with severe mastalgia and the therapeutic possibilities. Acta Obstet Gynecol Scand [Suppl] 123:185–188

    Article  CAS  Google Scholar 

  • Boever J de, Desmet B, Vandekerckhove D (1980) Variation of progesterone, 20-a-dihydroproges-terone and estradiol concentrations in human mammary tissue and blood after topical administration of progesterone. In: Mauvais-Jarvis P, Vickers CFH, Wepierre J (eds) Percutaneous absorption of steroids. Academic Press, London, pp 259–265

    Google Scholar 

  • Bogaert L-J van (1986) Mastodynie et maladie fibrokystique du sein. J Gynecol Obstet Biol Reprod 15:805–811

    Google Scholar 

  • Bohnet HG, Bertram M (1989) Die perioperativen Hormonspiegel bei praemenopausalen Patientinnen mit gutartigen Brustveränderungen und ihre Beeinflußbarkeit durch verschiedene Hormontherapien. Gynäkologe 22:255–261

    PubMed  CAS  Google Scholar 

  • Brookshaw JD (1979) Danazol treatment of benign breast disease: A survey of USA multi-centre-studies. Postgrad Med J [Suppl 5] 55:52–58

    Article  Google Scholar 

  • Colin C, Gaspard U, Lambotte R (1978) Relationship of mastodynia with its endocrine environment and treatment in a double blind trial with lynestrenol. Arch Gynecol 225:7–13

    CAS  Google Scholar 

  • Döberl A, Tobiassen T, Rasmussen TH (1984) Treatment of recurrent cyclical mastodynia in patients with fibrocystic breast disease. Acta Obstet Gynecol Scand [Suppl] 123:177–184

    Article  Google Scholar 

  • Dogliotti L, Mussa A, Sandrucci S (1983) Prolactin and benign breast disease with special emphasis to bromocriptin therapy. In: Angeli A, Bradlow HL, Dogliotti L (eds) Benign breast disease. Ravens, New York, pp 273–284

    Google Scholar 

  • Dogliotti L, Orlandi F, Forta M (1986) Bromocriptine treatment of fibrocystic breast disease. A survey. In: Dogliotti L, Mansel RE (eds) Fibrocystic breast disease. Cantor, Aulendorf, pp 46–53

    Google Scholar 

  • Fentinam IS, Calefi M, Brame K, Chandary MA, Hayword JL (1986) Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet 1:287–288

    Google Scholar 

  • Fournier D von, Grumbrecht C (1987) Behandlung der Mastopathie, Mastodynie und des praemen-struellen Syndroms. Therapiewoche 37:430–434

    Google Scholar 

  • Fournier D von, Kubli F, Bauer M, Weber E (1981) Hochdosierte Gestagen-Langzeittherapie beim Korpus-Karzinom, Einfluß auf Überlebenszeit. Geburtshilfe Frauenheilkd 41:266–269

    Article  Google Scholar 

  • Fournier D von, Kubli F, Junkermann H, Bauer M, Leger U, Arabin B, Müller A (1984) Medikamentöse und operative Therapie der Mastopathie in Abhängigkeit vom Entartungsrisiko. Frauenarzt 4:27–39

    Google Scholar 

  • Fournier D von, Junkermann H, Weber E (1987) Prospective studies of danazol, tamoxifen, progestogen and other hormones in benign breast diseases. Part II: Diagnosis and treatment. In: Wood C (ed) Benign breast disease: Is it worse treating? (Medical Sciences Royal Soc Med Sciences Round-table Series No 6, London, pp 74–83)

    Google Scholar 

  • Goebel R (1984) Results of a clinical evaluation of danazol in benign breast disease compared with local treatment, gestagens and bromocriptine. In: Baum M, George WD, Hughes LE (eds) Benign breast disease. Royal Society of Medicine, London (International Congress and Symposium Series No 76, pp 115–120)

    Google Scholar 

  • Goebel R, Junkermann H, Fournier D von (1989) Danazoltherapie bei gutartigen Brusterkrankungen. Gynäkologe 22:262–270

    PubMed  CAS  Google Scholar 

  • Greenblatt RB, Dmowski WP, Mahesh VB, Scholer HFL (1971) Clinical studies with an antigonado-tropindanazol. Fert Steril 22:102–112

    CAS  Google Scholar 

  • Greenblatt RB, Nezhat C, Ben-Nun J (1980) The treatment of benign breast disease with Danazol. Fertil Steril 34:242–245

    PubMed  CAS  Google Scholar 

  • Gregl A (1986) Klinik und Therapie der Mastopathie. In: Gregl A, Bässler R, Spona J (Hrsg) Patho-morphologie, Endokrinologie, Klinik und Therapie der Mastopathie. Informed, Gräfelfing (Medizin Aktuell: Benigne Brusterkrankungen, S 30–38)

    Google Scholar 

  • Herrmann U, Walther M (1983) Mastodynie: Differentialdiagnose und Therapie. Ther Umsch 40: 620–629

    PubMed  Google Scholar 

  • Hinton CP, Dowle C, Licker A, Roebuck EJ, Blarney RW (1988) Modification of the national history of cystic disease of the breasts by a short course of danazol: Evidence from a controlled trial. Br J Clin Pract [Suppl 4] 56:56–57

    Google Scholar 

  • Humphrey LJ, Estes NC (1979) Aspects of fibrozystic disease of the breast. Treatment with danazol. Postgrad Med J [Suppl 5] 55:48–52

    PubMed  Google Scholar 

  • Krause W, Wichmann U, Horn W (1987) Zur Resorption von Progesteron durch die intakte Haut der Brust im Vergleich zu anderen Körperregionen. Geburtshilfe Frauenheilkd 47:562–564

    Article  PubMed  CAS  Google Scholar 

  • Kumar S, Manod RE, Hughes LE, Edwards CA, Scanion MF (1985) Prediction of response to endocrine therapy in pronounced cyclical mastalgia using dynamic tests of prolactin release. Clin Endocrinol 23:699–704

    Article  CAS  Google Scholar 

  • Lauersen NH, Wilson ICH (1976) The effect of danazol in the treatment of chronic mastitis. Obstet Gynecol 48:93–98

    PubMed  CAS  Google Scholar 

  • Maddox P, Mansel R (1988) The treatment of mastalgia. Breast News 2:1–6

    Google Scholar 

  • Mansel RE, Wisbey JR, Hughes LE (1982) Controlled trial of the anti-gonadotropin Danazol in painful nodular benign breast disease. Lancet 1:928–931

    Article  PubMed  CAS  Google Scholar 

  • Maddox PR, Harrison BJH, Mansel RE (1988) Low dose danazol for mastalgia. Br J Clin Pract [Suppl] 42:21

    Google Scholar 

  • Navarro NS, Frauendorff RA (1988) Danazol for fibrocystic disease of the breast among Filipinos. Southeast Asian J Surg 11:17–21

    Google Scholar 

  • Peters F, Breckwoldt M (1985) Serum-Prolaktinspiegel bei Patientinnen mit Mastopathie. Klinische Bedeutung. Verh Dtsch Ges Path 69:401–404

    CAS  Google Scholar 

  • Peters F, Reck G, Zimmermann G, Breckwoldt M (1980) The effect of danazol on the pituitary function, thyroid function and mastodynia. Arch Gynecol 230:3–8

    Article  PubMed  CAS  Google Scholar 

  • Peters F, Pickart CR, Breckwoldt M (1983) Hormonal status of women with benign cystic breast disease: Clinical applications. In: Angeli A, Bradlow H, Dogliotti L (eds) Endocrinology of cystic breast disease. Raven, New York, pp 113–122

    Google Scholar 

  • Peters F, Geisthövel F, Breckwoldt M (1987) Treatment of benign breast diseases by dopamine agonists. In: Genazzani AR, Volpe A, Facchinetti F (eds) Gynecological Endocrinology. Parthenon, Lancaster, pp 275–283

    Google Scholar 

  • Schindler AE (1988) Danazol for the treatment of benign breast disease. In: Melis GB, Fournier D von (eds) Beyond symptomatic relief: Danazol in recurring feminine disorders. Parthenon, Lancaster, pp 41–51

    Google Scholar 

  • Schindler AE, Schindler E-M (1989) Wirkungsmechanismen von Danazol, eigene klinische Erfahrungen und Richtlinien für die Behandlung gutartiger Brusterkrankungen. Gynäkologe 22:271–273

    PubMed  CAS  Google Scholar 

  • Sutton GLJ, O’Malley VP (1986) Treatment of cyclical mastalgia with low dose short term danazol. Br J Clin Pract 40:68–70

    PubMed  CAS  Google Scholar 

  • Tobiassen T, Rasmussen T, Döberl A, Rannevik G (1984) Danazol treatment of severely symptomatic fibrocystic breast disease and long-term follow-up — the Hjorring project. Acta Obstet Gynecol Scand [Suppl] 123:159–176

    Article  CAS  Google Scholar 

  • Tolino A (1986) Benign breast disease and bromocriptin. G Ital Senolog 7:17–22

    Google Scholar 

  • Vorherr H (1986) Fibrocystic breast disease: Pathophysiology, pathomorphology, clinical picture and management. Am J Obstet Gynecol 154:161–179

    PubMed  CAS  Google Scholar 

  • Wang DY, Fentinam IS (1985) Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat 6:5–36

    Article  PubMed  CAS  Google Scholar 

  • Wingrave SJ (1982) Progestogen effects and their relationship to lipoprotein changes. A report on the oral contraception study of the Royal College of General Practitioners. Acta Obstet Gynecol Scand [Suppl] 105:33–36

    Article  CAS  Google Scholar 

Download references

Authors
  1. A. E. Schindler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Frauenklinik und Hebammenlehranstalt, Justus-Liebig-Universität, Klinikstraße 32, 6300, Gießen, Bundesrepublik Deutschland

    Wolfgang Künzel (Gf. Direktor) (Gf. Direktor)

  2. Frauenklinik, Justus-Liebig-Universität, Klinikstraße 32, 6300, Gießen, Bundesrepublik Deutschland

    Michael Kirschbaum

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schindler, A.E. (1989). Therapie der Mastodynie/Mastopathie. In: Künzel, W., Kirschbaum, M. (eds) Gießener Gynäkologische Fortbildung 1989. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-50217-0_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-50217-0_27

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-51234-9

  • Online ISBN: 978-3-642-50217-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation